Outbreak of wound botulism in injecting drug users

Epidemiology and Infection

Volumn 137, Issue 11, 2009, Pages 1602-1608

  Schroeter, M ^a   Alpers, K ^b   Van Treeck, U ^a   Frank, C ^b   Rosenkoetter, N ^a   Schaumann, R ^c  

^a North Rhine Westphalia   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Clostridium botulinum; Drug abuse; Heroin; Outbreak investigation; Parenteral molecular typing; Wound botulism

Indexed keywords

ANTITOXIN; CLINDAMYCIN; DIAMORPHINE; IMIPENEM; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; ANIMAL EXPERIMENT; ANTIBIOTIC SENSITIVITY; ARTICLE; AWARENESS; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BOTULISM; CLINICAL ARTICLE; CLOSTRIDIUM BOTULINUM; CONTAMINATION; CONTROLLED STUDY; CRANIAL NERVE PARALYSIS; DRUG USE; DYSPHAGIA; DYSPNEA; EPIDEMIC; FEMALE; GERMANY; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ABUSE; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PTOSIS; QUESTIONNAIRE; RURAL AREA; SYMPTOM; GENETICS; HEROIN DEPENDENCE; MICROBIOLOGY; MIDDLE AGED; PULSED FIELD GEL ELECTROPHORESIS; SUBSTANCE ABUSE; WOUND INFECTION;

ADULT; BOTULISM; CLOSTRIDIUM BOTULINUM; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GERMANY; HEROIN DEPENDENCE; HUMANS; MALE; MIDDLE AGED; SUBSTANCE ABUSE, INTRAVENOUS; WOUND INFECTION; YOUNG ADULT;

EID: 70349579090     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809002544     Document Type: Article

References (32)

1. Robert Koch-Institut. Annual report on reportable communicable diseases for 2004 [in German]. Berlin : Robert Koch-Institut, 2004, pp. 50-51.
2. Treeck Van U. Regarding an outbreak of wound botulism in North-Rhine-Westphalia [in German]. Epidemiologisches Bulletin 2005; 45: 420.
3. Treeck Van U, Alpers K. Update to the outbreak of wound botulism among injecting drug users in North- Rhine-Westphalia [in German]. Epidemiologisches Bulletin 2005; 48: 453.
4. Alpers K, Van Treeck U, Frank C. Outbreak of wound botulism in injecting drug users in Germany, October-December 2005. Eurosurveillance Weekly Release 2005; 12.
5. Ackermann G, et al. Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA. Antimicrobial Agents and Chemotherapy 2001; 45: 2348-2353.
6. Takeshi K, et al. Simple method for detection of Clostridium botulinum type A to F neurotoxin genes by ploymerase chain reaction. Microbiology and Immunology 1996; 40: 5-11.
7. Lindström M, et al. Multiplex PCR assay for detection and identification of Clostridium botulinum types A, B, E, and F in food and fecal material. Applied and Environmental Microbiology 2001; 67: 5694-5699.
8. Schaumann R, et al. Inducible metronidazole resistance in nim-positive and nim-negative Bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates. Infection 2005; 33: 368-372.
9. Schaumann R, Laurin F, Rodloff AC. Molecular typing of clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and random primer PCR fingerprinting. International Journal of Hygiene and Environmental Health 2008; 211: 292-298.
10. Tenover FC, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis : criteria for bacterial strain typing. Journal of Clinical Microbiology 1995; 33: 2233-2239.
11. Tuazon CU, Miller H, Shamsuddin D. Antimicrobial activity of street heroin. Journal of Infectious Diseases 1980; 142: 944.
12. McLauchlin J, et al. An investigation into the microflora of heroin. Journal of Medical Microbiology 2002; 51: 1001-1008.
13. Brett MM, Hallas G, Mpamugo O. Wound botulism in the UK and Ireland. Journal of Medical Microbiology 2004; 53: 555-561.
14. Merrison AF, et al. Wound botulism associated with subcutaneous drug use. British Medical Journal 2002; 325: 1020-1021.
15. CDC. Botulism in the United States, 1899-1996. In: Handbook for Epidemiologists, Clinicians, and Laboratory Workers. Atlanta, GA: Centers for Disease Control and Prevention, 1998.
16. Critchley EM, Hayes PJ, Isaacs PE. Outbreak of botulism in north west England and Wales, June, 1989. Lancet 1989; 2: 849-853.
17. Akbulut D, et al. Wound botulism in injectors of drugs: upsurge in cases in England during 2004. Eurosurveillance 2005; 10: 172-174.
18. Akbulut D, Grant KA, McLauchlin J. Improvement in laboratory diagnosis of wound botulism and tetanus among injecting illicit-drug users by use of realtime PCR assays for neurotoxin gene fragments. Journal of Clinical Microbiology 2005; 43: 4342-4348.
19. Passaro DJ, et al. Wound botulism associated with black tar heroin among injecting drug users. Journal of the American Medical Association 1998; 279: 859-863.
20. Werner SB, et al. Wound botulism in California, 1951-1998: recent epidemic in heroin injectors. Clinical Infectious Diseases 2000; 31: 1018-1024.
21. Brett MM, et al. Soft tissue infections caused by sporeforming bacteria in injecting drug users in the United Kingdom. Epidemiology and Infection 2005; 133: 575-582.
22. CDC. Wound botulism among black tar heroin users - Washington, 2003. Morbidity and Mortality Weekly Report 2003; 52: 885-886.
23. Kimura AC, et al. Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clinical Infectious Diseases 2004; 38: 87-91.
24. Bundeskriminalamt. Rauschgiftjahresbericht 2002 Bundesrepublik Deutschland. (http://www.bka.de/lageber ichte/rg/2002/jahresbericht-2002.pdf). Accessed 20 March 2009.
25. European Monitoring Centre for Drugs and Drug Addiction. Annual report 2006: the state of the drugs problem in Europe (http://ar2006.emcdda.europa.eu/ en/home-en.html). Accessed 20 March 2009.
26. Schröter M, et al. Epidemiological dynamics of hepatitis C virus among 747 German individuals : new subtypes on the advance. Journal of Clinical Microbiology 2002; 40: 1866-1868.
27. Wylie JL, Shah L, Jolly AM. Demographic, risk behaviour and personal network variables associated with prevalent Hepatitis C, Hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada. BMC Public Health 2006; 6: 229 (http://www.biomedcentral.com/ 1471-2458/6/229).
28. Gordon RJ, Lowy FD. Bacterial infections in drug users. New England Journal of Medicine 2005; 353: 1945-1954.
29. Fowler A, Mackay A. Community-acquired methicillin resistant Staphylococcus aureus pyomyositis in an intravenous drug user. Journal of Medical Microbiology 2006; 55: 123-125.
30. Gutzwiller FS, et al. Botulism: prevention, clinical diagnosis, therapy and possible threat. Deutsche Medizinische Wochenschrift 2008; 133: 840-845.
31. Cooper JG, et al. Clostridium botulinum: an increasing complication of heroin misuse. European Journal of Emergency Medicine 2005; 12: 251-252.
32. Wainberg MA. The need to promote public health in the field of illicit drug use. Canadian Medical Association Journal 2006; 175: 1395-1396.